$664 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 55 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 135.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $68,470,000 | +41.9% | 1,257,720 | +8.7% | 10.31% | +80.9% |
| CCK | Buy | CROWN HOLDINGS INC | $35,364,000 | +37.0% | 487,507 | +24.8% | 5.33% | +74.8% |
| XBI | Buy | SPDR SERIES TRUSTput | $33,289,000 | +172.9% | 350,000 | +118.8% | 5.01% | +248.0% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $29,604,000 | +90.0% | 1,224,825 | +51.1% | 4.46% | +142.3% |
| CSTM | New | CONSTELLIUM SE | $27,844,000 | – | 2,077,925 | +100.0% | 4.19% | – |
| ALLY | New | ALLY FINL INC | $21,821,000 | – | 714,040 | +100.0% | 3.29% | – |
| CROX | New | CROCS INC | $18,147,000 | – | 433,213 | +100.0% | 2.73% | – |
| ATNX | Buy | ATHENEX INC | $17,561,000 | +169.1% | 1,150,000 | +114.4% | 2.64% | +243.1% |
| RPD | Buy | RAPID7 INC | $17,488,000 | +30.8% | 312,168 | +6.0% | 2.63% | +66.8% |
| GSAH | New | GS ACQUISITION HLDGS CORP | $14,865,000 | – | 1,347,647 | +100.0% | 2.24% | – |
| WSC | Buy | WILLSCOT CORP | $14,625,000 | +28.4% | 790,952 | +8.2% | 2.20% | +63.7% |
| MDCO | New | MEDICINES COput | $12,741,000 | – | 150,000 | +100.0% | 1.92% | – |
| XLC | New | SELECT SECTOR SPDR TRput | $12,067,000 | – | 225,000 | +100.0% | 1.82% | – |
| CDEV | New | CENTENNIAL RESOURCE DEV INCcl a | $11,781,000 | – | 2,550,000 | +100.0% | 1.78% | – |
| MOMO | New | MOMO INCadr | $11,361,000 | – | 339,149 | +100.0% | 1.71% | – |
| FAST | New | FASTENAL CO | $9,977,000 | – | 270,000 | +100.0% | 1.50% | – |
| PTCT | Buy | PTC THERAPEUTICS INC | $9,784,000 | +58.0% | 203,711 | +11.2% | 1.47% | +101.4% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $9,727,000 | +172.5% | 695,500 | +28.4% | 1.46% | +247.2% |
| GDI | New | GARDNER DENVER HLDGS INC | $7,996,000 | – | 218,000 | +100.0% | 1.20% | – |
| CARA | Buy | CARA THERAPEUTICS INC | $7,597,000 | +47.5% | 471,575 | +67.3% | 1.14% | +88.2% |
| VEEV | New | VEEVA SYS INC | $4,220,000 | – | 30,000 | +100.0% | 0.64% | – |
| TMQ | Buy | TRILOGY METALS INC NEW | $4,081,000 | +69.6% | 1,569,446 | +8.3% | 0.62% | +116.5% |
| PVG | Buy | PRETIUM RES INC | $3,850,000 | +11.5% | 345,889 | +15.3% | 0.58% | +42.2% |
| XAIR | Buy | BEYOND AIR INC | $2,811,000 | +52.4% | 537,471 | +34.1% | 0.42% | +94.0% |
| PRPL | New | PURPLE INNOVATION INC | $2,777,000 | – | 318,791 | +100.0% | 0.42% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INCput | $2,768,000 | – | 100,000 | +100.0% | 0.42% | – |
| ATNX | New | ATHENEX INCcall | $2,291,000 | – | 150,000 | +100.0% | 0.34% | – |
| SCYX | New | SCYNEXIS INC | $2,088,000 | – | 2,294,444 | +100.0% | 0.32% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INCcall | $2,026,000 | – | 100,000 | +100.0% | 0.30% | – |
| GNCA | Buy | GENOCEA BIOSCIENCES INC | $1,517,000 | -23.8% | 733,050 | +6.8% | 0.23% | -2.6% |
| XCUR | New | EXICURE INC | $1,001,000 | – | 350,000 | +100.0% | 0.15% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $885,000 | – | 43,669 | +100.0% | 0.13% | – |
| MAS | New | MASCO CORP | $463,000 | – | 9,648 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
| ISHARES TR | 27 | Q3 2023 | 13.2% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
| META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
| AMAZON COM INC | 18 | Q3 2022 | 7.6% |
| SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
| FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
| Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
| Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.